A Pinch of Salt today set sail very far away! We went to the other side of the Atlantic ocean, transversed a few thousand km or miles of land and finally got to Katherine Tuttle, from Washington USA, an eminent specialist on translational medicine who will « unconfuse » us on the « new drugs in nephrology » a series of innovative treatments or indications for currently existing ones. We‘ll talk about SGLT2 inhibitors, Mineralocorticoid receptor antagonists and many more! Because that's the objective of A Pinch of Salt! We are looking for common-sense answers to difficult clinically relevant questions. Our basic mission is to ask the questions a young nephrologist would want to ask at the ERA Congress but doesn’t have the guts to do so out of fear of appearing a simpleton. We firmly believe that the so-called “simple questions” may be the most important ones and are too rarely asked and answered. So join us for this most exciting exchange with an eminent specialist in the field.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related